Abstract
Various methods have been used in the past to assess the implication of oxygen free radicals (OFR) in ischemia-reperfusion-induced cardiac injury. Luminol-enhanced tert-butyl-initiated chemiluminescence in cardiac tissue reflects oxidative stress and is a very sensitive method. It was used to elucidate the role of OFR in cardiac injury due to ischemia and reperfusion. Studies were conducted on perfused isolated rabbit hearts in three groups (n = 8 in each): I, control; II, submitted to global ischemia for 30 min; III, submitted to ischemia for 30 min followed by reperfusion for 60 min. The heart tissue was then assayed for chemiluminescence (CL); content of malondialdehyde (MDA), an indicator of OFR-induced cardiac injury; and activity of tissue levels of antioxidants [superoxide dismutase (SOD), catalase, glutathione peroxidase (GSH-Px)].
The control values for left and right ventricular CL and malondialdehyde were 81.1 ± 15.4 (S.E.) and 182.4 ± 50.3 (S.E.), mv-min-mg protein−1; and 0.024 ± 0.006 (S.E.) and 0.324 ± 0.005 (S.E.) nmoles-mg protein−1 respectively. Ischemia produced an increase in the cardiac CL (3.3 to 4.4 fold) and MDA content (2 to 2.6 fold). Reperfusion following ischemia also produced similar changes in CL and MDA content. The control values for activity of left ventricular SOD, catalase, and GSH-Px were 45.77 ± 1.73 (S.E.) U-mg protein−1 5.35 ± 0.51 (S.E.) K-10−3-sec−1-mg protein−1, and 77.50 ± 7.70 (S.E.) nmoles NADPH-min−1-mg protein−1 respectively. Activities of SOD and catalase decreased during ischemia but were similar to control values in ischemic-reperfused hearts. The GSH-Px activity of left ventricle was unaffected by ischemia, and ischemia-reperfusion. GSH-Px activity of the right ventricle increased with ischemia, and ischemic-reperfusion.
These results indicate that cardiac tissue chemiluminescence would be a useful and sensitive tool for the detection of oxygen free radical-induced cardiac injury.
Similar content being viewed by others
References
Jolly SR, Kane WJ, Bailie MB, Abrams GD, Lucchesi BR: Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 54: 277–285, 1984
Gardner TJ, Stewart JR, Casale AS, Downey JM, Chambers DE: Reduction of myocardial ischemic injury with oxygen derived free radical scavengers. Surgery 94: 423–427, 1983
Shlafer M, Kane PF, Wiggins VY, Kirsh MM: Possible role for cytotoxic oxygen metabolites in the pathogenesis of cardiac ischemic injury. Circulation 66 (Suppl I): 85–92, 1982
Prasad K, Kalra J, Chaudhary AK, Debnath D: Effect of polymorphonuclear leukocyte derived oxygen free radicals and hypochlorous acid on cardiac function and some biochemical parameters. Am Heart J 119: 538–550, 1990
Rao PS, Cohen MV, Mueller HS: Production of free radicals and lipid peroxides in early experimental myocardial ischemia. J Mol Cell Cardial 15: 713–716, 1983
Zweier JL: Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for free radical mechanism of reperfused injury. J Biol Chem 263: 1353–1357, 1988
Freeman BA, Crapo JD: Biology of disease. Free radicals and tissue injury. Lab Invest 47: 412–426, 1982
Meerson FZ, Kagan VE, Kozlov YP, Belkina LM, Arkhipenko YV: The role of lipid peroxidation in pathogenesis of ischemic damage and antioxidant protection of the heart. Basic Res Cardiol 77: 465–485, 1982
Halliwell B, Gutteridge MC: Oxygen radicals and tissue damage. In: CM Caldarera, P Harris (eds.) Advances in Studies on Heart Metabolism. Cooperativa Libraria Universitavia Editrice Bologna, Bologna, 1982, pp 403–411
Guarnieri C, Flamigni F, Caldarera CM: Role of oxygen in the cellular damage induced by re-oxygenation of hypoxic heart. J Mol Cell Cardiol 12: 797–808, 1980
Salin MC, McCord JM: Superoxide dismutases in polymorphonuclear leukocytes. J Clin Invest 54: 1005–1009, 1974
Campbell AK, Holt ME, Patel A: Chemiluminescence in medical biochemistry. In: GMM Albertini, CP Price (eds.) Recent Advances in Clinical Chemistry. Vol III. Churchill Livingstone, Edinburgh, 1984, pp 1–30
Dechatelet CR, Shirley PS: Evaluation of chronic granulomatous diseases by chemiluminescent assay of microlitre quantities of whole blood. Clin Chem 27: 1739–1741, 1981
Prasad K, Kalra J, Bharadwaj B: Increased chemiluminescence of polymorphonuclear leukocytes in dogs with volume overload heart failure. Br J Exp Path 70: 463–468, 1989
Prasad K, Kalra J, Chan WP, Chaudhary AK: Effect of oxygen free radicals on cardiovascular function at organ and cellular level. Am Heart J 117: 1196–1202, 1989
Tono-oko T, Veno N, Matsumoto T: Chemiluminescence of whole blood. A simple and rapid method for the estimation to phagocytic function of granulocytes and opsonic activity in whole blood. Clin Immun Immunopath 26: 66–75, 1983
Barsacchi R, Camici P, Bottigh U, et al.: Correlation between hydroperoxide-induced chemiluminescence of the heart and its function. Biochem Biophys Acta 62: 241–247, 1983
Cadenas E, Sies H: Low level of chemiluminescence of liver microsomal fractions initiated by tert-butyl hydroperoxide. Relation to microsomal hemoproteins, oxygen dependence and lipid peroxidation. Eur J Biochem 124: 349–356, 1982
Milei J, Boveris A, Llesuy S, et al.: Amelioration of adriamycininduced cardiotoxicity in rabbits by prenylamine and vitamins A and E. Am Heart J 111: 95–102, 1986
Cadenas E, Boveris A, Chance B: Low levels chemiluminescence of bovine heart submitochondrial particles. Biochem J 186: 659–667, 1980
Cadenas E, Varsavsky AI, Boveris A, Chance B: Oxygen or organic hydroperoxide-induced chemiluminescence of brain and liver homogenates. Biochem J 198: 645–654, 1981
Langendorff O: Untersuchungen am uberlebenden saugethierherzen. Pflugers Arch 61: 291–332, 1895
LKB-Wallac 1251 Luminometer Manual: The study of phagocytosis and opsonisation using luminol enhanced chemiluminescence. Application Note 513. Wallac of Finland, 1985, pp 1–5
Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15: 212–216, 1976
Prasad K, Kalra J: Experimental atherosclerosis and oxygen free radicals. Angiology 40: 835–843, 1989
Sun Y, Peterson TE, McCormick ML, Oberley LW, Osborne JW: Improved superoxide dismutase assay for clinical use. Clin Chem 35: 1265–1266, 1989
Aebi H: Catalase. In: HV Bergmeyer (eds.) Methods of enzymatic analysis. Chemie, Weinheim, F.R.G, 1974, pp 673–684
Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158–169, 1967
Lawrence RA, Burk RF: Glutathione peroxidase activity in selenium deficient rat to liver. Biochem Biophys Res Commun 71: 952–958, 1976
Barsacchi R, Pelosi G, Camici P, Bonaldo L, Mairino M, Ursini F: Glutathione depletion increases chemiluminescence emission and lipid peroxidation in the heart. Biochim Biophys Acta 804: 356–360, 1984
Boveris A, Cadenas E, Reiter R, Filipkowski M, Nakase Y, Chance B: Organ chemiluminescence: Noninvesive assay for oxidative radical reactions. Proc Natl Acad Sci (USA) 77: 347–351, 1980
Cadenas E, Wefers H, Sies H: Low-level chemiluminescence of isolated hepatocytes. Eur J Biochem 119: 531–536, 1981
Sugioka K, Nakano M: A possible mechanism of the generation of singlet molecular oxygen in NADPH-dependent microsomal lipid peroxidation. Biochem Biophys Acta 423: 203–216, 1976
Nakano M, Noguchi T, Sugioka K, Fukuyama H, Sato M: Spectroscopic evidence for the generation of singlet oxygen in the reduced nicotnamide adenine dinucleotide phosphate-dependent microsomal lipid peroxidative system. J Biol Chem 250: 2404–2406, 1975
Rao PS, Cohen MV, Mueller HS: Sequential transcardiac changes in free radicals, carecholamines and lipid peroxides in early experimental myocardial ischemia. In: R Greenwald, G Cohen (eds.) Oxyradicals and their scavenger systems. Vol 2. Elsevier Publication Co., New York, 1983, pp 357–360
Julicher RHM, Tijburg LBM, Sterrenberg L, Bast A, Koomen JM, Noordhoek J: Decreased defense against free radicals in rat heart during normal perfusion after hypoxic, ischemic and calcium-free perfusion. Life Sci 35: 1281–1288, 1984
Chambers DE, Parks DA, Patterson G, et al.: Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Coll Cardiol 17: 145–152, 1985
Kihlström M, Kainulainen H, Salminen A: Enzymatic and nonenzymatic lipid peroxidation capacities and antioxidants in hypoxic and reoxygenated rat myocardium. Exp Mol Pathol 50: 230–238, 1989
McCord JM, Roy RS: The pathophysiology of superoxide: Roles in inflammation and ischemia. Can J Physiol Pharmacol 60: 1346–1352, 1982
Hodgson EK, Fridovich I: The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: Chemilumescence and peroxidation. Biochemistry 14: 5294–5299, 11975
Frank L, Messaro D: Oxygen toxicity. Am J Med 69: 117–126, 1980
Oei HH, Stroo WE, Burton KP, Schaffer SW: A possible role of xanthine oxidase in producing oxidative stress in the heart of chronically ethanol treated rats. Res Commun Chem Pathol Pharmacol 38: 453–461, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prasad, K., Lee, P., Mantha, S.V. et al. Detection of ischemia-reperfusion cardiac injury by cardiac muscle chemiluminescence. Mol Cell Biochem 115, 49–58 (1992). https://doi.org/10.1007/BF00229095
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00229095